Safety, Tolerability, Antiemetic Efficacy, and Pharmacokinetics of Oral Dolasetron Mesylate in Pediatric Cancer Patients Receiving Moderately to Highly Emetogenic Chemotherapy.

Autor: Coppes, Max J., Yanofsky, Rochelle, Pritchard, Sheila, Leclerc, Jean-Marie, Howard, Danny R., Perrotta, Maria, Keays, Sharon, Pyesmany, Allan, Dempsey, Ellen, Pratt, Charles B.
Zdroj: Journal of Pediatric Hematology/Oncology; Jul/Aug1999, Vol. 21 Issue 4, p274-283, 10p
Databáze: Complementary Index